$2.52
-0.04-1.56%
Last update: Oct 5, 7:15 AM
$2.66
0.103.91%

Kiora Pharmaceuticals (KPRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.62 | $-0.70 | $-0.54 | $-0.72 |
| Actual | $-0.34 | $-0.58 | $-1.60 | $0.01 |
| Surprise | +45.2% | +17.1% | -196.3% | +101.4% |
| Revenue | ||||
| Estimate | — | $1.5M | $1.5M | $750000 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.41 | $-0.42 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.34 | $-0.62 | 45.2 % |
| Q1 | May 8, 2026 | $-0.58 | $-0.70 | 17.1 % |
| Q4 | Mar 25, 2026 | $-1.60 | $-0.54 | -196.3 % |
| Q3 | Nov 7, 2025 | $0.01 | $-0.72 | 101.4 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 8, 2026 | $0 | $1.50M | -100.0 % |
| Q4 | Mar 25, 2026 | $0 | $1.50M | -100.0 % |
| Q3 | Nov 7, 2025 | $0 | $750.00K | -100.0 % |
| Q2 | Aug 8, 2025 | $0 | $750.00K | -100.0 % |